StockData
ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30

ASHLAND INC.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$71.19+0.04 (+0.06%)

Close on Oct 19, 2026

Market cap
$3.27K
P/E (TTM)
–
Dividend yield
2.30%

About Ashland

Wholesale-Chemicals & Allied Products, SIC 5160

Ashland Inc. produces specialty additives and functional ingredients for consumer and industrial applications across four operating segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences provides pharmaceutical polymers and nutritional formulation ingredients to drug manufacturers, healthcare facilities, and food producers. Personal Care supplies nature-derived ingredients, active compounds, and specialty polymers to consumer brands for skin care, hair care, oral care, and cleaning products. Specialty Additives manufactures performance-enhancing additives and rheology modifiers for paint, construction, and energy companies. The Intermediates segment produces 1,4 butanediol and chemical solvents for industrial, polymer, and electronic manufacturing.

The business operates across the Americas, Europe, and the Asia Pacific region, marketing its products in more than 100 countries. It maintains manufacturing and laboratory facilities in countries such as the United States, Brazil, China, Germany, and India, with additional derivative production in Texas and Kentucky. Ashland employs approximately 2,900 people worldwide and maintains its principal executive offices in Wilmington, Delaware.

Summary of the business section of Ashland's latest annual report, written by StockData.

Company profile

Company

Legal name
ASHLAND INC.
Founded
1924
Headquarters
Wilmington, DE
Address
8145 Blazer Drive 19808
Phone
(304) 995-3000
Employees
2,900, Sep 30, 2025
Industry
Wholesale-Chemicals & Allied Products
Incorporated in
Delaware
Fiscal year ends
September 30
Auditor
Ernst & Young LLP, Grandview Heights, Ohio

Stock & identifiers

Ticker
ASH
Exchange
NYSE
Shares outstanding
46M, Jun 30, 2026
Public float
$2.70B, Mar 31, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jul 29, 1988
SEC CIK
1674862
CUSIP
044186104
ISIN
US0441861046
LEI
529900E4L9R04SB8HB11
EIN
81-2587835

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Guillermo NovoChair of the Board and CEO, Director172,143
Osama M. MusaSVP and CTO37,577
Robin E. LampkinSVP, GC & Secretary7,690
Alessandra Faccin AssisSVP and GM, Life Sciences9,099
James P. MinicucciSVP and GM, Personal Care8,567
William WhitakerSVP, CFO & PFO2,082
Eileen DrurySVP and Chief HRO7,601
Dago CaceresSVP & GM, Specialty Additives746
Samuel RichardsonVP, Controller and PAO1,072
Eric N. BoniVP, Finance & Prinpl Acctg Off22,770
J. Kevin WillisSVP and CFO270,566
Karl R. BostaphSenior VP Operations7,165
Allen A. SpizzoDirector–
Peter T. ThomasDirector4,500
Steven D. BishopDirector–
Sanat ChattopadhyayDirector–
Bertrand LoyDirector–
Ashish K. KulkarniDirector2,113
Suzan F. HarrisonDirector1,931
Sue MainDirector1,883
Jerome A. PeribereDirector1,883
Scott TozierDirector–
Sergio PedreiroDirector–
Janice TealDirector1,883

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$7.87M-$2.86M$2.27M$74$129
FY2024$8.73M$12.25M$2.74M$130$154
FY2023$6.97M$239.76K$2.18M$120$135
FY2022$9.32M$12.90M$2.07M$137$114
FY2021$7.60M$9.13M$1.72M$127$128

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of September 30, 2025, Ashland had approximately 2,900 employees in more than 100 countries.”

Corporate history

Events identified from SEC filings